Efficacy and Safety of Artesunate Plus Standard of Care in Active Lupus Nephritis

NCT03214731 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Lupus Nephritis

Interventions

DRUG: Artesunate
OTHER: placebo

Sponsor

Sun Yat-sen University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]